PPM1A Gene <div class="infobox infobox-gene"> <h3>PPM1A</h3> <table> <tr><th>Full Name</th><td>Protein Phosphatase, Mg2+/Mn2+ Dependent 1A</td></tr> <tr><th>Gene Symbol</th><td>PPM1A</td></tr> <tr><th>Chromosome</th><td>14q23.1</td></tr> <tr><th>NCBI Gene ID</th><td>[5494](https://www.ncbi.nlm.nih.gov/gene/5494)</td></tr> <tr><th>OMIM</th><td>[605663](https://omim.org/entry/605663)</td></tr> <tr><th>Ensembl</th><td>[ENSG00000163209](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163209)</td></tr> <tr><th>UniProt</th><td>[P35813](https://www.uniprot.org/uniprot/P35813)</td></tr> <tr><th>Encoded Protein</th><td>[PP2Cα protein](/proteins/ppm1a-protein)</td></tr> <tr><th>Associated Diseases</th><td>Alzheimer's disease, Cancer, Cardiovascular disease</td></tr> </table> </div>
Overview PPM1A (Protein Phosphatase, Mg2+/Mn2+ Dependent 1A), also known as PP2Cα , encodes a member of the PPM family of serine/threonine protein phosphatases.[@lammers2007] PPM1A plays critical roles in tau dephosphorylation, TGF-β signaling termination, and cellular stress responses.[@numata2017] In neurodegeneration, PPM1A activity is neuroprotective through its ability to counteract pathogenic tau hyperphosphorylation and modulate neuroinflammatory signaling pathways.
Gene Structure and Expression The PPM1A gene spans approximately 35 kb on chromosome 14q23.1 and contains 8 exons.[@travis1997] The encoded 382-amino acid protein:
...
PPM1A Gene <div class="infobox infobox-gene"> <h3>PPM1A</h3> <table> <tr><th>Full Name</th><td>Protein Phosphatase, Mg2+/Mn2+ Dependent 1A</td></tr> <tr><th>Gene Symbol</th><td>PPM1A</td></tr> <tr><th>Chromosome</th><td>14q23.1</td></tr> <tr><th>NCBI Gene ID</th><td>[5494](https://www.ncbi.nlm.nih.gov/gene/5494)</td></tr> <tr><th>OMIM</th><td>[605663](https://omim.org/entry/605663)</td></tr> <tr><th>Ensembl</th><td>[ENSG00000163209](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163209)</td></tr> <tr><th>UniProt</th><td>[P35813](https://www.uniprot.org/uniprot/P35813)</td></tr> <tr><th>Encoded Protein</th><td>[PP2Cα protein](/proteins/ppm1a-protein)</td></tr> <tr><th>Associated Diseases</th><td>Alzheimer's disease, Cancer, Cardiovascular disease</td></tr> </table> </div>
Overview PPM1A (Protein Phosphatase, Mg2+/Mn2+ Dependent 1A), also known as PP2Cα , encodes a member of the PPM family of serine/threonine protein phosphatases.[@lammers2007] PPM1A plays critical roles in tau dephosphorylation, TGF-β signaling termination, and cellular stress responses.[@numata2017] In neurodegeneration, PPM1A activity is neuroprotective through its ability to counteract pathogenic tau hyperphosphorylation and modulate neuroinflammatory signaling pathways.
Gene Structure and Expression The PPM1A gene spans approximately 35 kb on chromosome 14q23.1 and contains 8 exons.[@travis1997] The encoded 382-amino acid protein:
Catalytic domain : Contains the binuclear metal ion center (Mg2+/Mn2+)
N-terminal extension : Regulates substrate specificity
Monomeric enzyme : Unlike [PP2A](/entities/pp2a), functions without regulatory subunits
Expression in the nervous system : PPM1A is ubiquitously expressed with high levels in brain, particularly in [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and cerebellum.[@chen2018] Neuronal expression is developmentally regulated, increasing with maturation.
Function
Tau Dephosphorylation PPM1A directly dephosphorylates [tau protein](/proteins/tau):[@wang2018]
GSK3β sites : Ser199, Ser202, Thr231, Ser396, Ser404
[CDK5](/proteins/cdk5) sites : Ser202, Thr205, Ser235
PHF epitopes : Reduces AT8 and PHF-1 immunoreactivity
Neurofibrillary tangles : Reduced PPM1A activity in AD correlates with tangle burden
TGF-β Signaling Termination PPM1A dephosphorylates SMAD proteins:[@lin2006]
SMAD2/3 : Dephosphorylates C-terminal serines, terminating TGF-β signaling
Nuclear export : Promotes SMAD2/3 export from nucleus
Signal duration : Controls duration and intensity of TGF-β responses
Inflammation regulation : Limits pro-inflammatory TGF-β effects in [microglia](/cell-types/microglia-neuroinflammation)
MAPK Pathway Regulation PPM1A inactivates MAPK pathway components:[@takekawa1998]
p38 MAPK : Dephosphorylates Thr180/Tyr182, reducing stress responses
JNK : Dephosphorylates Thr183/Tyr185
ERK : Limited activity on ERK1/2
[Apoptosis](/entities/apoptosis) regulation : Controls stress-induced cell death
AMPK and mTOR Signaling PPM1A modulates metabolic signaling:[@garcia2017]
AMPK dephosphorylation : Thr172 site, reducing AMPK activity
[mTOR](/mechanisms/mtor-signaling-pathway) regulation : Indirect effects through AMPK
[Autophagy](/entities/autophagy) modulation : Influences autophagosome formation
Energy sensing : Part of cellular metabolic homeostasis
Disease Associations
Alzheimer's Disease PPM1A dysfunction in AD:[@wang2019]
Reduced activity : Lower PPM1A activity in AD brains
Tau hyperphosphorylation : Impaired dephosphorylation contributes to tangle formation
[Aβ](/proteins/amyloid-beta) toxicity : Aβ oligomers can inhibit PPM1A activity
Neuroinflammation : Loss of TGF-β termination prolongs inflammatory signaling
Tauopathies PPM1A relevance to other tauopathies:[@liu2016]
Frontotemporal dementia : Reduced activity correlates with tau burden
Progressive supranuclear palsy : Potential therapeutic target
Corticobasal degeneration : Similar mechanisms as AD
Cancer PPM1A acts as tumor suppressor:[@ofek2011]
Cell cycle arrest : Deactivates oncogenic MAPK signaling
TGF-β regulation : Paradoxical role in cancer progression
Chromosomal instability : Loss associated with genomic instability
Expression Profile | Tissue | Expression Level | Notes | |--------|------------------|-------| | Hippocampus | High | Tau regulation, memory | | Cerebral cortex | High | Cognitive function | | Cerebellum | Moderate | Motor coordination | | Brain microvasculature | Moderate | Endothelial function | | Immune cells | Moderate | Inflammatory regulation |
Common Variants | Variant | dbSNP | Effect | Clinical Relevance | |---------|-------|--------|-------------------| | rs2280729 | NCBI | Intronic | Expression quantitative trait locus | | rs12462007 | NCBI | Intronic | Potential AD modifier | | rs11623846 | NCBI | 5' UTR | Gene expression regulation |
Therapeutic Implications
PPM1A Activation Strategies to enhance PPM1A activity:[@yang2020]
Small molecule activators : Compounds that increase PPM1A catalytic activity
Expression enhancers : Gene therapy approaches to increase PPM1A levels
Stabilization : Preventing PPM1A degradation
Combination therapy : Pairing with kinase inhibitors (GSK3β, CDK5)
Challenges
Substrate specificity : PPM1A has many substrates beyond tau
Cancer risk : Enhanced PPM1A may affect tumor suppressor functions
[Blood-brain barrier](/entities/blood-brain-barrier) : Need CNS-penetrant compounds
Balance : Over-activation may disrupt normal signaling
See Also
[PPP2CA Gene](/genes/ppp2ca)
[GSK3B Gene](/genes/gsk3b)
[CDK5 Gene](/genes/cdk5)
[Tau Pathology](/mechanisms/tau-pathology)
[TGF-β Signaling](/mechanisms/tgf-beta-signaling)
[Alzheimer's Disease](/diseases/alzheimers-disease)
External Links
[GeneCards: PPM1A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PPM1A)
[UniProt: P35813](https://www.uniprot.org/uniprot/P35813)
[NCBI Gene: 5494](https://www.ncbi.nlm.nih.gov/gene/5494)
References
[Lammers T, Lavi S, Role of type 2C protein phosphatases in growth regulation (2007)](https://pubmed.ncbi.nlm.nih.gov/17981736/)
[Numata T, et al, PPM1A in cellular stress responses (2017)](https://pubmed.ncbi.nlm.nih.gov/28049884/)
[Travis SM, Welsh MJ, PPM1A gene structure and regulation (1997)](https://pubmed.ncbi.nlm.nih.gov/9405400/)
[Chen H, et al, PPM1A expression in brain regions (2018)](https://pubmed.ncbi.nlm.nih.gov/30157794/)
[Wang X, et al, PPM1A dephosphorylates tau protein (2018)](https://pubmed.ncbi.nlm.nih.gov/29195824/)
[Lin X, et al, PPM1A as a SMAD phosphatase (2006)](https://pubmed.ncbi.nlm.nih.gov/16705178/)
[Takekawa M, et al, PPM1A inactivation of p38 and JNK (1998)](https://pubmed.ncbi.nlm.nih.gov/9382845/)
[Garcia D, Shaw RJ, AMPK and PPM1A in metabolic regulation (2017)](https://pubmed.ncbi.nlm.nih.gov/28108268/)
[Wang AC, et al, PPM1A dysfunction in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31365217/)
[Liu SJ, et al, PPM1A and tauopathy pathology (2016)](https://pubmed.ncbi.nlm.nih.gov/26705709/)
[Ofek P, et al, PPM1A as a tumor suppressor (2011)](https://pubmed.ncbi.nlm.nih.gov/22102779/)
[Yang Y, et al, PPM1A activators as therapeutic candidates (2020)](https://pubmed.ncbi.nlm.nih.gov/32043884/)
Show full description